These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 9842467)
21. Influence of aminopeptidase inhibitors on brain angiotensin metabolism and drinking in rats. Wright JW; Quirk WS; Hanesworth JM; Harding JW Brain Res; 1988 Feb; 441(1-2):215-20. PubMed ID: 3359232 [TBL] [Abstract][Full Text] [Related]
22. Aminopeptidase A, generating one of the main effector peptides of the brain renin-angiotensin system, angiotensin III, plays a key role in central control of blood pressure. Rozenfeld R; Reaux A; Iturrioz X; Fassot C; Fournie-Zaluski MC; David C; Maigret B; Roques BP; Corvol P; Llorens-Cortes C Proc West Pharmacol Soc; 2003; 46():39-44. PubMed ID: 14699881 [No Abstract] [Full Text] [Related]
24. Effects of intraventricular injection of Sar1-Ala8-angiotensin II on plasma vasopressin level increased by angiotensin II and by water deprivation in conscious rats. Yamaguchi K; Hama H; Sakaguchi T; Negoro H; Kamoi K Acta Endocrinol (Copenh); 1980 Apr; 93(4):407-12. PubMed ID: 7386111 [TBL] [Abstract][Full Text] [Related]
25. Central antihypertensive effects of chronic treatment with RB150: an orally active aminopeptidase A inhibitor in deoxycorticosterone acetate-salt rats. Marc Y; Hmazzou R; Balavoine F; Flahault A; Llorens-Cortes C J Hypertens; 2018 Mar; 36(3):641-650. PubMed ID: 28968260 [TBL] [Abstract][Full Text] [Related]
26. Effects of angiotensin III on protein, DNA, and collagen synthesis of neonatal cardiomyocytes and cardiac fibroblasts in vitro. Wang HX; Zhang QF; Zeng XJ; Wang W; Tang CS; Zhang LK J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4):393-402. PubMed ID: 20861513 [TBL] [Abstract][Full Text] [Related]
27. The in vivo metabolism of cholecystokinin (CCK-8) is essentially ensured by aminopeptidase A. Migaud M; Durieux C; Viereck J; Soroca-Lucas E; Fournié-Zaluski MC; Roques BP Peptides; 1996; 17(4):601-7. PubMed ID: 8804068 [TBL] [Abstract][Full Text] [Related]
28. Role of intracerebral angiotensin receptors in the regulation of vasopressin release and the cardiovascular system. Shoji M; Kimura T; Matsui K; Ota K; Iitake K; Inoue M; Yoshinaga K Neuroendocrinology; 1986; 43(2):239-44. PubMed ID: 3014365 [TBL] [Abstract][Full Text] [Related]
29. Structure-function analyses of brain angiotensin control of pressor action in rats. Wright JW; Jensen LL; Roberts KA; Sardinia MF; Harding JW Am J Physiol; 1989 Dec; 257(6 Pt 2):R1551-7. PubMed ID: 2604011 [TBL] [Abstract][Full Text] [Related]
30. The luminal membrane of rat thick limb expresses AT1 receptor and aminopeptidase activities. Poumarat JS; Houillier P; Rismondo C; Roques B; Lazar G; Paillard M; Blanchard A Kidney Int; 2002 Aug; 62(2):434-45. PubMed ID: 12110004 [TBL] [Abstract][Full Text] [Related]
31. Effects of i.c.v. losartan on the angiotensin II-mediated vasopressin release and hypothalamic fos expression in near-term ovine fetuses. Shi L; Mao C; Wu J; Morrissey P; Lee J; Xu Z Peptides; 2006 Sep; 27(9):2230-8. PubMed ID: 16677737 [TBL] [Abstract][Full Text] [Related]
32. Investigation of the active site of aminopeptidase A using a series of new thiol-containing inhibitors. Chauvel EN; Coric P; Llorens-Cortès C; Wilk S; Roques BP; Fournié-Zaluski MC J Med Chem; 1994 Apr; 37(9):1339-46. PubMed ID: 7909847 [TBL] [Abstract][Full Text] [Related]
33. [A comparison between the effects of angiotensin II and angiotensin III injected into the third cerebral ventricle on vasopressin secretion in conscious rats (author's transl)]. Yamaguchi K; Negoro H; Hama H; Kamoi K; Sakaguchi T Nihon Naibunpi Gakkai Zasshi; 1979 Oct; 55(10):1286-95. PubMed ID: 510629 [TBL] [Abstract][Full Text] [Related]
34. Hypothalamic Renin-Angiotensin System and Lipid Metabolism: Effects of Virgin Olive Oil versus Butter in the Diet. Segarra AB; Domínguez-Vías G; Redondo J; Martínez-Cañamero M; Ramírez-Sánchez M; Prieto I Nutrients; 2021 Jan; 13(2):. PubMed ID: 33572630 [TBL] [Abstract][Full Text] [Related]
35. Targeting Brain Aminopeptidase A: A New Strategy for the Treatment of Hypertension and Heart Failure. Marc Y; Boitard SE; Balavoine F; Azizi M; Llorens-Cortes C Can J Cardiol; 2020 May; 36(5):721-731. PubMed ID: 32389345 [TBL] [Abstract][Full Text] [Related]
36. Novel role of aminopeptidase-A in angiotensin-(1-7) metabolism post myocardial infarction. Alghamri MS; Morris M; Meszaros JG; Elased KM; Grobe N Am J Physiol Heart Circ Physiol; 2014 Apr; 306(7):H1032-40. PubMed ID: 24464749 [TBL] [Abstract][Full Text] [Related]
37. NI956/QGC006, a Potent Orally Active, Brain-Penetrating Aminopeptidase A Inhibitor for Treating Hypertension. Keck M; De Almeida H; Compère D; Inguimbert N; Flahault A; Balavoine F; Roques B; Llorens-Cortes C Hypertension; 2019 Jun; 73(6):1300-1307. PubMed ID: 31067198 [TBL] [Abstract][Full Text] [Related]
38. Characterization of renin-angiotensin system enzyme activities in cultured mouse podocytes. Velez JC; Bland AM; Arthur JM; Raymond JR; Janech MG Am J Physiol Renal Physiol; 2007 Jul; 293(1):F398-407. PubMed ID: 17429035 [TBL] [Abstract][Full Text] [Related]
39. Peptidase inhibitor-induced antidiuresis mediated through angiotensin and opioid receptors in the rat hypothalamus. Tsushima H; Mori M; Matsuda T Jpn J Pharmacol; 1996 May; 71(1):61-71. PubMed ID: 8791172 [TBL] [Abstract][Full Text] [Related]
40. Orally active aminopeptidase A inhibitors reduce blood pressure: a new strategy for treating hypertension. Bodineau L; Frugière A; Marc Y; Inguimbert N; Fassot C; Balavoine F; Roques B; Llorens-Cortes C Hypertension; 2008 May; 51(5):1318-25. PubMed ID: 18362226 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]